{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:14:33Z","timestamp":1782177273404,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.vascn.2004.11.005","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T08:56:44Z","timestamp":1105606604000},"page":"264-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs"],"prefix":"10.1016","volume":"52","author":[{"given":"S\u00e1ndor","family":"Farkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Berzsenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egon","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Tarnawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2004.11.005_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2003.10.035","article-title":"Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats","volume":"153","author":"Arshaduddin","year":"2004","journal-title":"Behavioral Brain Research"},{"key":"10.1016\/j.vascn.2004.11.005_bib2","first-page":"265","article-title":"The pharmacological properties of \u03b1:\u03b2 dihydroxy-\u03b3-(2-methylphenoxy)-propane (Myanesin)","volume":"1","author":"Berger","year":"1946","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)25657-9","article-title":"Unusual muscle relaxant and analgesic properties of N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (Carisoprodol)","volume":"127","author":"Berger","year":"1959","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2004.11.005_bib4","first-page":"43","article-title":"Studies on the mechanism of action of RGH-5002, a centrally acting muscle relaxant, using whole cell patch clamp technique","volume":"5","author":"Bielik","year":"1997","journal-title":"Neurobiology"},{"key":"10.1016\/j.vascn.2004.11.005_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00439104","article-title":"The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON-954","volume":"52","author":"Coward","year":"1977","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib6","first-page":"2326","article-title":"The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent","volume":"27","author":"Coward","year":"1977","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"key":"10.1016\/j.vascn.2004.11.005_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0028-3908(77)90004-1","article-title":"Central transmitter involvement in LON-954-induced tremorogenesis","volume":"1","author":"Coward","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00235314","article-title":"The differential effects of baclofen on segmental and descending excitation of spinal interneurones in the cat","volume":"58","author":"Curtis","year":"1985","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.vascn.2004.11.005_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(74)90109-9","article-title":"A comparative study of dantrolene sodium and other skeletal muscle relaxants with the Straub-tail mouse","volume":"13","author":"Ellis","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib11","series-title":"Spasticity: The current status of research and treatment","first-page":"153","article-title":"Review of clinical trials with tizanidine (Sirdalud) in spasticity","author":"Emre","year":"1989"},{"key":"10.1016\/j.vascn.2004.11.005_bib12","series-title":"Spasticity: Mechanisms and management","first-page":"372","article-title":"New developments in the medical treatment of spasticity","author":"Emre","year":"1993"},{"key":"10.1016\/j.vascn.2004.11.005_bib13","first-page":"57","article-title":"Comparative characterisation of the centrally acting muscle relaxant RGH-5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro","volume":"5","author":"Farkas","year":"1997","journal-title":"Neurobiology"},{"key":"10.1016\/j.vascn.2004.11.005_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1056-8719(02)00169-7","article-title":"Validation of a new computerized system for recording and analyzing drug-induced tremor in rats","volume":"46","author":"Fonseca","year":"2002","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2004.11.005_bib15","first-page":"341","article-title":"Effects of 2-amino-5-chlorobenzoxazol on the central nervous system","volume":"14","author":"Funderburk","year":"1955","journal-title":"Federation Proceedings"},{"key":"10.1016\/j.vascn.2004.11.005_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0773.1985.tb00007.x","article-title":"Harmine, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol","volume":"57","author":"Gothoni","year":"1985","journal-title":"Acta Pharmacologica et Toxicologica"},{"key":"10.1016\/j.vascn.2004.11.005_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(90)90611-9","article-title":"Dopamine D2 receptors and spinal cord excitation in mice","volume":"184","author":"Hasegawa","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: A new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-3565(25)22641-6","article-title":"Tetrazepam: A benzodiazepine which dissociates sedation from other benzodiazepine activities: I. Psychopharmacological profile in rodents","volume":"245","author":"Keane","year":"1988","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2004.11.005_bib20","first-page":"49","article-title":"Mydeton: A centrally acting muscle relaxant drug from Gedeon Richter","volume":"72","author":"Kocsis","year":"2002","journal-title":"Acta Pharmaceutica Hungarica"},{"key":"10.1016\/j.vascn.2004.11.005_bib21","first-page":"391","article-title":"Effects of E-0646 on cases of spasticity: A double-blind comparison using tolperisone hydrochloride","volume":"9","author":"Kuroiawa","year":"1981","journal-title":"Clinical Evaluation"},{"key":"10.1016\/j.vascn.2004.11.005_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(74)90067-3","article-title":"Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative","volume":"26","author":"Maj","year":"1974","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1254\/jjp.73.215","article-title":"Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats","volume":"73","author":"Matsunaga","year":"1997","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-4328(03)00094-9","article-title":"Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice","volume":"145","author":"Mehta","year":"2003","journal-title":"Behavioral Brain Research"},{"key":"10.1016\/j.vascn.2004.11.005_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0731-7085(87)80082-1","article-title":"Gas\u2013liquid chromatographic method for the determination of tolperisone in human plasma: Pharmacokinetic and bioavailability studies","volume":"5","author":"Miskolczi","year":"1987","journal-title":"Journal of Pharmaceutical & Biomedical Analysis"},{"key":"10.1016\/j.vascn.2004.11.005_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0361-9230(89)90042-7","article-title":"Tremorogenesis by LON-954 [N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride]: Evidence for the involvement of 5-hydroxytryptamine","volume":"22","author":"Mohanakumar","year":"1989","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.vascn.2004.11.005_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/jm020067s","article-title":"Indanylidenes: 1. Design and synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity","volume":"46","author":"Musso","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.vascn.2004.11.005_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archneur.1997.00550180049011","article-title":"Relationship of antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis","volume":"54","author":"Nance","year":"1997","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.vascn.2004.11.005_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01061374","article-title":"Tizanidine in the treatment of spasticity","volume":"23","author":"Newman","year":"1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ddr.430020407","article-title":"Studies on the efficacy and depressant potential of muscle relaxants in mice","volume":"2","author":"Novack","year":"1982","journal-title":"Drug Development Research"},{"key":"10.1016\/j.vascn.2004.11.005_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0021-5198(19)52811-6","article-title":"Pharmacological studies on 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3h)-quinazolinone (afloqualone), a new centrally acting muscle relaxant: I","volume":"31","author":"Ochiai","year":"1981","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0021-5198(19)52663-4","article-title":"Pharmacological studies on 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3h)-quinazolinone (afloqualone), a new centrally acting muscle relaxant: II. Effects on the spinal reflex potential and rigidity","volume":"32","author":"Ochiai","year":"1982","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib34","first-page":"257","article-title":"Pharmacologie einer neuen interneuron-lahmenden Substanz 1-piperidino-2-methyl-3-(p-tolyl)-propan-3-on","volume":"11","author":"P\u00f3rsz\u00e1sz","year":"1961","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.vascn.2004.11.005_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0304-3959(96)03187-9","article-title":"Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful muscle spasm: Results of a prospective placebo-controlled double-blind trial","volume":"67","author":"Pratzel","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.vascn.2004.11.005_bib36","series-title":"Pharmacology","first-page":"544","author":"Rang","year":"1996"},{"key":"10.1016\/j.vascn.2004.11.005_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(94)00666-U","article-title":"Pharmacological properties of NK433 a new centrally acting muscle relaxant","volume":"273","author":"Sakitama","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2004.11.005_bib38","first-page":"272","article-title":"Comparative study of tetrazepam and other centrally acting muscle relaxants","volume":"297","author":"Simiand","year":"1989","journal-title":"Archives Internationales de Pharmacodynamie et de Therapie"},{"key":"10.1016\/j.vascn.2004.11.005_bib39","series-title":"Investigations with a peculiar tremorogenic compound: IX. Internat Congress of Neuropathology (Vienna) I-98","first-page":"209","author":"Sineger","year":"1982"},{"issue":"Suppl. 32","key":"10.1016\/j.vascn.2004.11.005_bib40","first-page":"119","article-title":"Pharmacological profile of flupirtine, a novel centrally acting, non-opioid analgesic drug","author":"Szelenyi","year":"1991","journal-title":"Agents and Actions"},{"key":"10.1016\/j.vascn.2004.11.005_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0160-9327(86)90093-1","article-title":"Sila-substitution\u2014a useful strategy for drug design","volume":"10","author":"Tacke","year":"1986","journal-title":"Endeavour"},{"key":"10.1016\/j.vascn.2004.11.005_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1254\/fpj.77.511","article-title":"Effects of 4\u2032-ethyl-2-methyl-3-piperidinopropiophenone on experimental contracture and spinal cord activities","volume":"77","author":"Tanaka","year":"1981","journal-title":"Folia Pharmacologica Japonica"},{"key":"10.1016\/j.vascn.2004.11.005_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(01)02166-8","article-title":"Baclofen attenuates harmaline induced tremor in rats","volume":"312","author":"Tariq","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.vascn.2004.11.005_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM198101013040107","article-title":"Drug therapy: Spasticity","volume":"304","author":"Young","year":"1981","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871904001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871904001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:51:38Z","timestamp":1761004298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871904001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1056871904001133"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2004.11.005","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2004.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}